Quest Diagnostics Incorporated
Mark E Delaney (SVP & Chief Commercial Officer) reports DGX insider transactions
AI-generated summary
SVP & Chief Commercial Officer Mark E Delaney reported 25 shares in code L transactions at an average price of $235.94 for a total value of $5,898.53 on October 21, 2026. Following these transactions, the insider directly held 10,360 shares of Common Stock. No Rule 10b5-1 trading plan was used for this report.
Key facts
- Insider
- Mark E Delaney · SVP & Chief Commercial Officer
| Date | Transaction | Shares | Price | Value | Held after | Ownership |
|---|---|---|---|---|---|---|
| Oct 21, 2026 | LFootnotes F1 | +25 | $235.94 | $5,898.52 | 10,360 | Direct |
Footnotes
- F1 Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker and eligible for deferred reporting on Form 5 under Rule 16a-6. The reporting person has chosen to report such transaction early on this Form 4.
More DGX filings
- 144
Filed Nov 3, 2026
- 4
Filed Oct 28, 2026
- 144
Filed Oct 26, 2026
- 4
Filed Oct 23, 2026
- 4
Filed Oct 23, 2026
- 4
Filed Oct 23, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.